GENE ONLINE|News &
Opinion
Blog

2025-12-02|

Study Finds Veterans Face Persistent Health Challenges from Long COVID

by GOAI
Share To

Recent research has highlighted the long-term health challenges faced by veterans who have contracted COVID-19. The study, conducted by researchers O’Hare, Montague, and Hynes and published in the *Journal of General Internal Medicine*, examines the lingering effects of the virus on this population. Veterans, often dealing with pre-existing conditions and unique health risks due to their service, appear to experience significant post-COVID complications.

The findings indicate that veterans are encountering a range of persistent symptoms following COVID-19 infection. These include respiratory issues, cardiovascular problems, mental health challenges such as anxiety and depression, and other chronic conditions. The study emphasizes that these long-term effects may be exacerbated by factors such as age, prior exposure to hazardous environments during military service, and underlying medical conditions common among veterans. Researchers analyzed data from healthcare systems serving veterans to better understand how COVID-19 impacts this group over time. This research contributes to ongoing efforts to address the broader implications of long COVID within vulnerable populations.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top